Discover the critical elements that influence stroke recovery outcomes, from timing of treatment to rehabilitation approaches ...

Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.

MicroTransponder has received $65m in a Series F financing round, which aims to enhance its stroke care offerings with the ...

Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

Genentech’s label expansion for TNKase consolidates its market position for pharmacological stroke treatments.

With its FDA-approved neurostimulator implant aimed at helping patients recover from stroke, MicroTransponder has raised $65 ...

The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.

In Alaska, where access to specialist care is challenging and emergency transfers can be harrowing, providers are using AI to ...

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

A report has warned that stroke victims are facing a postcode lottery to access lifesaving treatment. The Stroke Association ...

First Nations people in Australia's "stroke hotspot" have come together in a campaign to raise awareness of the symptoms.

Stroke can come out of the blue, even in people who have been healthy all their lives. Unlike some other health conditions that develop gradually, a stroke occurs suddenly when blood flow to the brain ...